共 50 条
- [21] TROUGH LEVELS OF INFLIXIMAB BETTER CORRELATE WITH COMBINED MUCOSAL AND TRANSMURAL HEALING THAN CLINICAL REMISSION IN KOREAN PATIENTS WITH CROHN'S DISEASE ON INFLIXIMAB MAINTENANCE THERAPYGASTROENTEROLOGY, 2019, 156 (06) : S1138 - S1139Oh, Eun HyeYoon, A-RanPark, Seong HoKim, JeongseokHam, NamseokSong, Eun MiHwang, Sung WookPark, Sang HyoungYang, Dong-HoonByeon, Jeong-SikMyung, Seung-JaeYang, Suk-KyunYe, Byong Duk
- [22] Trough levels of infliximab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn's disease on infliximab maintenance therapyJOURNAL OF CROHNS & COLITIS, 2019, 13 : S484 - S485Oh, E. H.Yoon, A. -R.Park, S. H.Kim, J.Ham, N.Song, E. M.Hwang, S. W.Park, S. H.Yang, D. -H.Byeon, J. -S.Myung, S. -J.Yang, S. -K.Ye, B. D.
- [23] Combined fibrin glue with infliximab therapy of postoperative anastomotic fistula in patients with Crohn's disease: A Pilot studyJOURNAL OF CROHNS & COLITIS, 2021, 15 : S444 - S445Li, Y.Yao, D.
- [24] A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's diseaseALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1126 - 1135Levesque, B. G.Greenberg, G. R.Zou, G.Sandborn, W. J.Singh, S.Hauenstein, S.Ohrmund, L.Wong, C. J.Stitt, L. W.Shackelton, L. M.King, D.Lockton, S.Ducharme, J.Feagan, B. G.
- [25] Combination Therapy with Infliximab and Thiopurine Compared to Infliximab Monotherapy in Maintaining Remission of Postoperative Crohn's DiseaseDIGESTION, 2015, 91 (03) : 233 - 238Sakuraba, AtsushiOkamoto, SusumuMatsuoka, KatsuyoshiSato, ToshiroNaganuma, MakotoHisamatsu, TadakazuIwao, YasushiOgata, HaruhikoKanai, TakanoriHibi, Toshifumi
- [26] Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trialBMJ OPEN, 2014, 4 (12):Buhl, Sine SchnoorSteenholdt, CasperBrynskov, JornThomsen, Ole OstergaardBendtzen, KlausAinsworth, Mark Andrew
- [27] The evolution of fatigue in patients with Crohn's disease after treatment with infliximab: A prospective studyGASTROENTEROLOGY, 2004, 126 (04) : A476 - A476Persoons, PDemyttenaere, KVandenberghe, JVan Oudenhove, LRutgeerts, P
- [28] Predictors of Sustained Response to Infliximab in Patients With Crohn's Disease: A Single Cohort StudyGASTROENTEROLOGY, 2011, 140 (05) : S593 - S593Duricova, DanaMalickova, KarinBortlik, MartinMachkova, NadezdaKomarek, ViktorBouzkova, EvaLukas, Milan
- [29] Maintenance therapy with infliximab for paediatric Crohn's disease: impact on clinical remission and mucosal healing in Polish paediatric patients with severe Crohn's diseasePRZEGLAD GASTROENTEROLOGICZNY, 2012, 7 (01): : 26 - 30Kierkus, JaroslawDadalski, MaciejSzymanska, SylwiaSzymanska, EdytaWegner, AgnieszkaGorczewska, MonikaOracz, GrzegorzWoynarowski, MarekRyzko, Jozef
- [30] Comparative study of infliximab and adalimumab induction therapy for clinical remission and mucosal healing in paediatric patients with active Crohn's diseaseJOURNAL OF CROHNS & COLITIS, 2016, 10 : S290 - S290Szymanska, E.Dadalski, M.Szymanska, S.Grajkowska, W.Pronicki, M.Jaroslaw, K.